RH director exercises options, sells 7,000 shares

RH director and officer Chaya Eri exercised stock options for 7,000 shares of common stock at an exercise price of $39.4200 per share, then sold all 7,000 shares in open-market transactions on March 17, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

The sales were executed in three tranches: 2,700 shares at a weighted average price of $134.5044, 3,292 shares at $135.7018, and 1,008 shares at $136.3972, under a Rule 10b5-1 trading plan adopted on October 7, 2024. After these transactions, Eri holds 43,000 stock options directly and 23,643 shares of common stock indirectly through the Chaya-Smith Revocable Trust.

Insider Trade Summary

Exercise and Sale: 7,000 shares ($671K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Chaya Eri

Role SEE REMARKS

Sold 7,000 shs ($947K)

Approx. gross sale proceeds $947K

Approx. exercise cost $276K

Approx. pre-tax spread $671K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	7,000	$0.00	$0.00
Exercise	Common Stock	7,000	$39.42	$276K
Sale	Common Stock	2,700	$134.5044	$363K
Sale	Common Stock	3,292	$135.7018	$447K
Sale	Common Stock	1,008	$136.3972	$137K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 43,000 contracts (Direct); Common Stock — 0 shares (Direct); Common Stock — 23,643 shares (Indirect, By Trust)

Footnotes (6)

F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024.
F2. This transaction was executed in multiple trades ranging from $134.10 to $135.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3. This transaction was executed in multiple trades ranging from $135.12 to $136.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4. This transaction was executed in multiple trades ranging from $136.15 to $136.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5. Held by the Chaya-Smith Revocable Trust.
F6. This option award is fully vested and exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RH insider Chaya Eri do in this Form 4 filing?

Chaya Eri exercised options for 7,000 RH common shares at $39.4200 each and sold all 7,000 shares in open-market trades. The filing details an exercise-and-sell sequence executed on March 17, 2026, rather than a net new share purchase.

How many RH shares did Chaya Eri sell and at what prices?

Chaya Eri sold 7,000 RH common shares in three tranches: 2,700 at $134.5044, 3,292 at $135.7018, and 1,008 at $136.3972. These represent weighted average prices for multiple trades within specified intraday ranges.

Was the RH insider sale by Chaya Eri under a Rule 10b5-1 plan?

Yes. The Form 4 states the RH share sales were effected under a Rule 10b5-1 trading plan adopted by Chaya Eri on October 7, 2024. Such plans pre-schedule trades, indicating the timing was established in advance rather than decided opportunistically.

What RH holdings does Chaya Eri report after these transactions?

Following the reported transactions, Chaya Eri holds 43,000 RH stock options directly and 23,643 RH common shares indirectly. The indirect shares are held through the Chaya-Smith Revocable Trust, while direct common stock holdings from the exercised lot were fully sold.

What type of derivative security did Chaya Eri exercise in RH?

Chaya Eri exercised a "Stock Option (Right to Buy)" covering 7,000 RH common shares at an exercise price of $39.4200 per share. The Form 4 notes this option award is fully vested and exercisable, and 43,000 options remain held directly afterward.

How does this RH Form 4 characterize the sales made by Chaya Eri?

The Form 4 characterizes the transactions as open-market sales of RH common stock, coded "S" for sale. It notes that each sale tranche was executed in multiple trades, with reported figures representing weighted average sale prices within specified price ranges.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 08:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chaya Eri

(Last)

(First)

(Middle)

C/O RH

15 KOCH ROAD, SUITE K

(Street)

CORTE MADERA

CALIFORNIA

94925

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RH [ RH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEE REMARKS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/17/2026		M		7,000	A	$39.42	7,000	D
Common Stock	03/17/2026		S		2,700	D	$134.5044⁽¹⁾⁽²⁾	4,300	D
Common Stock	03/17/2026		S		3,292	D	$135.7018⁽¹⁾⁽³⁾	1,008	D
Common Stock	03/17/2026		S		1,008	D	$136.3972⁽¹⁾⁽⁴⁾	0	D
Common Stock								23,643	I	By Trust⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$39.42	03/17/2026		M			7,000	⁽⁶⁾	05/03/2026	Common Stock	7,000	$0	43,000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024.

2. This transaction was executed in multiple trades ranging from $134.10 to $135.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

3. This transaction was executed in multiple trades ranging from $135.12 to $136.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

4. This transaction was executed in multiple trades ranging from $136.15 to $136.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

5. Held by the Chaya-Smith Revocable Trust.

6. This option award is fully vested and exercisable.

Remarks:

President, Co-Chief Creative and Merchandising Officer and Director

	/s/ Jill Falor, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR